InsiderClue
Insiders · Profile

Stengone Carmine N.

CEO and President at Contineum Therapeutics · Director at KIORA PHARMACEUTICALS. Filing since 11 Sep 2024. CIK 0001861519

CTNM Contineum Therapeutics, Inc. CEO and President · 7 trades KPRX KIORA PHARMACEUTICALS INC Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
CTNM Contineum Therapeutics, Inc.
8 Sep 2026
CEO and President
Sold on a plan
2,500
$41.14K
12.7%
CTNM Contineum Therapeutics, Inc.
3 Aug 2026
CEO and President
Sold on a plan
2,500
$40.03K
12.7%
CTNM Contineum Therapeutics, Inc.
8 Jul 2026
CEO and President
Sold on a plan
2,500
$40.00K
12.7%
CTNM Contineum Therapeutics, Inc.
30 Jun 2026
CEO and President
Sold on a plan
10,000
$160.08K
36.7%
CTNM Contineum Therapeutics, Inc.
25 Feb 2026
CEO and President
Sold on a plan
2,700
$43.24K
15.3%
CTNM Contineum Therapeutics, Inc.
24 Feb 2026
CEO and President
Sold on a plan
4,400
$70.49K
22.7%
CTNM Contineum Therapeutics, Inc.
11 Feb 2026
CEO and President
Sold on a plan
400
$6.40K
2.6%
KPRX KIORA PHARMACEUTICALS INC
11 Sep 2024
Director
Bought
1,250
$4.60K
opened
8 decisions on file.